SD
Scadden David
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Scadden David, Director. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 13 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €48k. History available since 28 May 2021. The latest transaction was filed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Scadden David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
2,816 sharesCommon stockSEC:0001439222-26-000095:0
200 shares@ US$18.093.7% of flowCommon stockSEC:0001439222-25-000120:0
200 shares@ US$18.093.8% of flowCommon stockSEC:0001439222-25-000108:0
200 shares@ US$18.093.9% of flowCommon stockSEC:0001439222-25-000106:0
200 shares@ US$18.094.1% of flowCommon stockSEC:0001439222-25-000100:0
1,400 shares@ US$18.0929.7% of flowCommon stockSEC:0001439222-25-000084:0
1,400 shares@ US$40.0065.6% of flowCommon stockSEC:0001439222-25-000084:1
2,120 shares0Common stockSEC:0001439222-25-000049:0
200 shares@ US$18.094.7% of flowCommon stockSEC:0001439222-24-000146:0
3,388 shares0Common stockSEC:0001439222-24-000079:0
4,975 shares0Common stockSEC:0001439222-23-000093:0
1,585 shares0Common stockSEC:0001439222-22-000053:0
1,686 shares0Common stockSEC:0001439222-21-000051:0
About Scadden David
Scadden David is Administrateur at AGIOS PHARMACEUTICALS, INC. and Agios Pharmaceuticals, INC. He has 13 filings in total, and in the sampled recent filings, the activity spans 2021-06-02 to 2026-06-23, with EUR 0 in buys and EUR 47852 in sales. The most frequent transaction nature is Levée d'options.